Literature DB >> 4936860

Therapeutics. XV. The management of Henoch-Schonlein purpura.

H Ashton, E Frenk, C J Stevenson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4936860     DOI: 10.1111/j.1365-2133.1971.tb07216.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  7 in total

1.  Pitfalls in recommending evidence-based guidelines for a protean disease like Henoch-Schönlein purpura nephritis.

Authors:  Jean-Claude Davin; Rosanna Coppo
Journal:  Pediatr Nephrol       Date:  2013-07-09       Impact factor: 3.714

2.  Clostridium difficile Infection and Inflammatory Bowel Disease.

Authors:  David Binion
Journal:  Gastroenterol Hepatol (N Y)       Date:  2016-05

3.  Henoch-Schonlein Purpura With Gastrointestinal Involvement in an Adult Patient.

Authors:  Dharmesh Kaswala; Ari Chodos; Sushil Ahlawat
Journal:  Gastroenterol Hepatol (N Y)       Date:  2016-05

4.  Henoch-Schönlein purpura.

Authors: 
Journal:  Br Med J       Date:  1977-01-22

5.  Anaphylactoid purpura presenting as a medical and surgical emergency.

Authors:  C V Clark; J A Hunter
Journal:  Br Med J (Clin Res Ed)       Date:  1983-07-02

6.  Corticosteroid therapy does not prevent nephritis in Henoch-Schönlein purpura.

Authors:  F T Saulsbury
Journal:  Pediatr Nephrol       Date:  1993-02       Impact factor: 3.714

Review 7.  Henoch-Schönlein purpura nephritis in children.

Authors:  Jean-Claude Davin; Rosanna Coppo
Journal:  Nat Rev Nephrol       Date:  2014-07-29       Impact factor: 28.314

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.